XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2020
Income Statement [Abstract]      
Revenue $ 874,332 $ 770,770 $ 696,264
Cost of revenue 249,484 224,738 215,577
Gross profit 624,848 546,032 480,687
Operating expenses:      
Research and development 218,523 201,262 199,750
Sales and marketing 298,635 275,742 317,615
General and administrative 135,316 106,670 102,794
Total operating expenses 652,474 583,674 620,159
Loss from operations (27,626) (37,642) (139,472)
Interest and other expense, net (9,838) (4,584) (3,466)
Loss before provision for income taxes (37,464) (42,226) (142,938)
Provision for income taxes 3,995 1,207 1,410
Net loss (41,459) (43,433) (144,348)
Dividend on series A convertible preferred stock (10,911)    
Accretion of series A convertible preferred stock (1,508)    
Net loss attributable to common stockholders $ (53,878) $ (43,433) $ (144,348)
Net loss per share attributable to common stockholders, basic and diluted $ (0.35) $ (0.28) $ (0.98)
Weighted-average shares used to compute net loss per share attributable to common stockholders, basic and diluted 155,598 155,849 147,762